DiscoverDaily Brief Podcast
Daily Brief Podcast
Claim Ownership

Daily Brief Podcast

Author: Albert Takem M.D

Subscribed: 2Played: 156
Share

Description

We tackle the health topics no one else wants to touch 💉🧠
 —from obesity and high blood pressure
 —to emotional eating and medication resistance
 —to cultural myths that keep people sick 🧬❌

My mission is to deliver evidence-based truth—
 real doctors. hard truths. no coddling. 🎯

🎧 Subscribe now and share with someone who’s tired of watered-down wellness.
 Let’s change lives with facts—not fluff.


201 Episodes
Reverse
Can Ozempic Make You Go Blind? Can Ozempic actually affect your eyesight? It is a frightening question, and unlike many alarming health headlines, there are real eye-related concerns involving semaglutide that patients should understand. But several very different eye problems often get collapsed into one frightening claim: “Ozempic causes blindness.” In this episode, Dr. Albert Takem separates two important issues. The first is diabetic retinopathy, which can sometimes temp...
Ozempic is Actually Aging You? You lose 40 or 50 pounds, your face looks thinner, and suddenly someone says, “Look what Ozempic did.” But is the medication actually aging your face—or are we blaming Ozempic for changes that can happen when anyone loses a significant amount of weight? In this episode, Dr. Albert Takem breaks down the concern often called “Ozempic face.” He explains what happens to facial fat during weight loss, why age, genetics, skin elasticity, smoking, sun...
Does Ozempic really paralyze your stomach? GLP-1 medications do slow how quickly food leaves the stomach. That is real, and it is part of how these medications help people feel full sooner. But slower gastric emptying is not the same thing as permanent stomach paralysis. In this episode, I explain what GLP-1 medications actually do to digestion, what gastroparesis means, and why frightening headlines can make a real medical effect sound very different from what is actually happeni...
“Doctor, I’m not taking Ozempic. Those drugs are too new. Nobody knows what they’re going to do to people 20 years from now.” It is a reasonable concern. If you may be taking a medication for years, you should care about its long-term safety. But there is an important distinction between uncertainty about the future and having no meaningful safety data at all. In this episode, Dr. Albert Takem puts the history of GLP-1 medications into perspective. The first GLP-1 receptor agonist...
Does the thyroid cancer warning on Ozempic mean semaglutide has been proven to cause thyroid cancer in people? The warning is real—but what it actually means is often misunderstood. In this episode, Dr. Albert Takem explains where the thyroid cancer warning for Ozempic and other GLP-1 medications came from, why tumors seen in rats and mice do not automatically prove the same risk in humans, and why the specific type of thyroid cancer matters. The concern centers on thyroid C-cell tumors an...
loading
CommentsÂ